SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-08-123792
Filing Date
2008-05-29
Accepted
2008-05-28 18:07:50
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT d10qa.htm 10-Q/A 15590
2 EXCLUSIVE LICENSE AGREEMENT dex101.htm EX-10.1 114530
3 EXCLUSIVE LICENSE AGREEMENT dex102.htm EX-10.2 103305
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9241
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9212
6 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4433
  Complete submission text file 0001193125-08-123792.txt   257730
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-29089 | Film No.: 08864525
SIC: 2836 Biological Products, (No Diagnostic Substances)